| 摘要 |
<p>Topical formulation contains pseudomonic acid (I) or its salt or ester and at least 1 wt.% of a poly (opt. substd. alkylene) glycol (II) or its deriv. Pref. salts of (I) are the alkali metal salts and pref. esters are the 1-4C alkyl esters. The formulation pref. contains 0.01-50 wt.% (I) (or salt or ester). Pref. (II) is polyethylene glycol (PEG) or its deriv. (esp. PEG 400 opt. contg. PEG 4000, glycofurol or cetomacrogol). The formulation may also contain antibacterial, antifungal, antiviral and/or antiinflammatory agents but pref. (I) is the sole therapeutic agent. Use amt. of (I) is esp. 0.5-10 (partic. 2) wt.%.S (I) is a known antibiotic (see GB1395907) useful for treating skin, ear and eye disorders by topical admin. (I) has improved stability in presence of (II). -</p> |
